TBPH vs BIIB: Which Stock is Better?
Side-by-side comparison of Theravance Biopharma Inc and Biogen Inc in 2026
TBPH
Theravance Biopharma Inc
—
BIIB
Biogen Inc
$216.03
Key Metrics Comparison
| Metric | TBPH | BIIB | Winner |
|---|---|---|---|
| Market Cap | $861.45M | $29.33B | BIIB |
| P/E Ratio | 7.49 | 21.39 | TBPH |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze TBPH
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TBPH or BIIB a better investment?
Comparing TBPH and BIIB: Theravance Biopharma Inc has a market cap of $861.45M while Biogen Inc has $29.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TBPH and BIIB?
TBPH (Theravance Biopharma Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TBPH or BIIB?
Based on P/E ratios, TBPH trades at a lower multiple (7.5x vs 21.4x).
Which is growing faster: TBPH or BIIB?
Both TBPH and BIIB show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: TBPH or BIIB?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: TBPH or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $29.33B compared to $861.45M for TBPH.
Should I buy TBPH or BIIB in 2026?
Both TBPH and BIIB have investment merit. TBPH trades at $N/A while BIIB trades at $216.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TBPH and BIIB stock?
Key differences: Market Cap ($861.45M vs $29.33B), P/E Ratio (7.5x vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy TBPH or BIIB in 2026?
The choice between TBPH and BIIB depends on your investment goals. BIIB shows higher revenue growth (0.0%). BIIB has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between TBPH and BIIB?
TBPH (Theravance Biopharma Inc) has a market cap of $861.45M, while BIIB (Biogen Inc) has a market cap of $29.33B. BIIB is the larger company by market value.